We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Rules For Apotex In Paxil Patent Suit

Law360 (April 26, 2004, 12:00 AM EDT) -- In a blow to U.K. drug maker GlaxoSmithKline, the U.S. Court of Appeals for the Federal Circuit has rejected a key claim for the U.S. patent covering Paxil (paroxetine hydrochloride), the world’s top-selling antidepressant.

Glaxo had sued Canadian generic maker Apotex, the first company to challenge the validity of patents covering Paxil and the first to gain approval from the U.S. Food and Drug Administration for a generic version of the drug.

Paxil is the leading antidepressant drug on the market with annual worldwide sales totaling...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.